Eduardo Willian de Alencar Pereira

Mr. Eduardo Willian de Alencar Pereira

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 April 2023 in Microbial Pathogenesis
Verified
Journal Article
Closed access
EPEduardo Willian de Alencar Pereira
Eduardo Willian de Alencar Pereira
VFValéria Fontes
Valéria Fontes
EAErika Alves da Fonseca Amorim
Erika Alves da Fonseca Amorim
RMRita de Cassia Miranda
Rita de Cassia Miranda
Rafael Cardoso CarvalhoRafael Cardoso Carvalho
Rafael Cardoso Carvalho
LNLidio Lima Neto
Lidio Lima Neto

31 May 2023 in Viruses
Verified
Journal Article
Open access
PDF file
VFValéria Fontes
Valéria Fontes
HFHivylla Lorrana dos Santos Ferreira
Hivylla Lorrana dos Santos Ferreira
MRMarilene Ribeiro
Marilene Ribeiro
APAruanã Joaquim Pinheiro
Aruanã Joaquim Pinheiro
CMCarlos Maramaldo
Carlos Maramaldo
LNLidio Lima Neto
Lidio Lima Neto
Introduction: Although fewer children have been affected by the severe form of the coronavirus disease 2019 (COVID-19), community-acquired pneumonia (CAP) continues to be the leading global cause of child hospitalizations and deaths. Aim: This study investigated the incidence of respiratory syncytial virus (RSV) as well its subtypes (RSV A and B), adenovirus (ADV), rhinovirus (HRV), metapneumovirus (HMPV), coronavirus (NL63, OC43, 229E and HKU1), parainfluenza virus subtypes (PI1, PI2 and PI3), bocavirus and influenza A and B viruses (FluA and FluB) in children diagnosed with CAP during the COVID-19 pandemic. Methods: A total of 200 children with clinically confirmed CAP were initially recruited, of whom 107 had negative qPCR results for SARS-CoV-2 and were included in this study. Viral subtypes were identified using a real-time polymerase chain reaction in the nasopharyngeal swab samples. Results: Viruses were identified in 69.2% of the patients. RSV infections were the most frequently identified (65.4%), with type RSV B being the most prevalent (63.5%). In addition, HCoV 229E and HRV were detected in 6.5% and 3.7% of the patients, respectively. RSV type B was associated with severe acute respiratory infection (ARI) and a younger age (less than 24 months). Conclusions: New strategies for preventing and treating viral respiratory infections, particularly RSV infections, are necessary.